[Al18F]PSMA137 PET/CT Imaging for PSMA-Positive Cancer Patients
Status:
Recruiting
Trial end date:
2023-12-12
Target enrollment:
Participant gender:
Summary
To investigate the radioactive uptake of [Al 18 F]PSMA137 in PCa patients, and evaluate the
ability of [Al 18 F]PSMA137 to detect PSMA overexpression in PCa patients (especially those
with recurrent or advanced PCa).To provide an approach for screening patients high expression
of PSMA, efficacy monitoring, drug resistance and early warning of recurrence and metastasis
to achieve the individualized antitumor treatment of targeted drugs.